3-chloro-2,2-dimethyl-propane-1-sulfonic acid amide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: 3-chloro-2,2-dimethyl-propane-1-sulfonic acid amide
• 英文别名: 3-Chlor-2,2-dimethyl-propan-1-sulfonsaeure-amid；3-Chlor-2,2-dimethyl-propan-1-sulfonamid；3-Chloro-2,2-dimethylpropane-1-sulfonamide
• 化学式: C₅H₁₂ClNO₂S
• 分子量: 185.675
• InChiKey: PFVXYJWUEHFZSZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  68.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-chloro-2,2-dimethylpropane-1-sulfonyl chloride 在 乙醚 、 氨 作用下， 生成 3-chloro-2,2-dimethyl-propane-1-sulfonic acid amide
  参考文献：
  名称：

  A Study of Aliphatic Sulfonyl Compounds. V. Neopentanesulfonyl Chloride¹

  摘要：

  DOI：

  10.1021/jo01110a002

文献信息

• NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
  申请人：Inflazome Limited

  公开号：US20200331850A1

  公开（公告）日：2020-10-22

  The present invention relates to compounds of formula (I): Formula (I) wherein Q is selected from O or S; L is a saturated or unsaturated, optionally substituted C 1 -C 12 hydrocarbylene group optionally including one or more heteroatoms N, O or S; R 1 is —NR 3 R 4 , —OR 5 , —(C═NR 6 )R 7 , —(CO)R 8 , —CN, —N 3 , a quaternary ammonium group or an optionally substituted heterocycle; R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently hydrogen or a saturated or unsaturated, optionally substituted C 1 -C 10 hydrocarbyl group optionally including one or more heteroatoms N, O or S; wherein optionally L and R 3 , or L and R 4 , or R 3 and R 4 , or L and R 5 , or L and R 6 , or L and R 7 , or R 6 and R 7 , or L and R 8 together with the atom(s) to which they are attached may form a 3- to 12-membered, saturated or unsaturated, optionally substituted cyclic group; and R 2 is a cyclic group substituted at the a-position, wherein R 2 may optionally be further substituted; provided that the atom of L which is attached to the sulfur atom of the sulfonylurea group is a carbon atom and is not a ring atom of a heterocyclic or aromatic group. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP 3 .
• [EN] NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS DE SULFONAMIDE CARBOXAMIDE
  申请人：INFLAZOME LTD

  公开号：WO2019034696A1

  公开（公告）日：2019-02-21

  The present invention relates to compounds of formula (I): Formula (I) wherein Q is selected from O or S; L is a saturated or unsaturated, optionally substituted C1-C12 hydrocarbylene group optionally including one or more heteroatoms N, O or S; R1 is -NR3R4, -OR5, -(C=NR6)R7, -(CO)R8, -CN, -N3, a quaternary ammonium group or an optionally substituted heterocycle; R3, R4, R5, R6, R7 and R8 are each independently hydrogen or a saturated or unsaturated, optionally substituted C1- C10 hydrocarbyl group optionally including one or more heteroatoms N, O or S; wherein optionally L and R3, or L and R4, or R3 and R4, or L and R5, or L and R6, or L and R7, or R6 and R7, or L and R8 together with the atom(s) to which they are attached may form a 3- to 12-membered, saturated or unsaturated, optionally substituted cyclic group; and R2 is a cyclic group substituted at the a-position, wherein R2 may optionally be further substituted; provided that the atom of L which is attached to the sulfur atom of the sulfonylurea group is a carbon atom and is not a ring atom of a heterocyclic or aromatic group. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
• A Study of Aliphatic Sulfonyl Compounds. V. Neopentanesulfonyl Chloride¹
  作者：ROBERT B. SCOTT、HARRY L. McLEOD

  DOI：10.1021/jo01110a002

  日期：1956.4